The primary and secondary objectives of the Early Developmental Stages of Substance Abuse Study (EDSP) are described along with a detailed description of the overall design, special design features and instruments used. The EDSP is a 5-year prospective study with three waves of assessments. Special design features are the linkages with family genetic investigations as well as neuroendocrinological stress tests in high-risk subjects. Overall, 3,021 adolescents and young adults aged 14-24 years are included. The response rate for the baseline investigation was 71%. Diagnostic assessments were made by using a modified lifetime (baseline) and 12-month change version of the WHO-CIDI, adjusted for DSM-IV. Modifications refer to a more detailed quantitative assessment of symptoms and substance use variables as well as the inclusion of questions to assess course of disorders and subthreshold diagnostic conditions.
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Background of the EDSP
The considerable overall deficit in knowledge about substance use disorders motivated the federal German government in 1994 to launch the 'Biological and Psychosocial Factors of Drug Abuse' program coordinated by the Ministry of Research and Technology. A major component of this fairly comprehensive long-term research program was the constitution of a working group in epidemiology to study a wide variety of issues related to prevalence, risk factors as well as the natural course of substance abuse in various sites and regions. This collaborative effort was labeled ANEPSA (Analytical Epidemiology of Psychoactive Substance Abuse), bringing together three major work groups: the Institute für Therapieforschung (IFT, München) with the focus on the long-term course and outcome of drug use as well as preventive trials, the Psychiatric Hospital of the University of Lü-beck, with the focus on the prevalence of substance use disorders among 18-to 65-year-olds as well as the study of remission from substance use disorders without formal treatment, and the Max Planck Institute of Psychiatry Unit for Clinical Psychology and Epidemiology for a longitudinal study on the early stages of substance abuse (EDSP) in a representative sample of adolescents and young adults aged 14-24 years. The ANEPSA group meets regularly and coordinates both the use of identical assessment instruments as well as comparable analytic strategies to allow systematic comparisons and joint analyses in the future. Two of the work groups also investigate the same respondents in different research projects. This paper describes the goals and methods used in the EDSP, Table 1 . Diagnostic criteria for substance use disorders in DSM-IV Criteria for substance dependence A A maladaptive pattern of substance use, leading to clinically significant impairment or distress, as manifested by three (or more) of the following, occurring at any time in the same 12-month period: 1 tolerance, as defined by either of the following: (a) a need for markedly increased amounts of the substance to achieve intoxication or desired effect (b) markedly diminished effect with continued use of the same amount of the substance 2 withdrawal, as manifested by either of the following:
(a) the characteristic withdrawal syndrome for the substance (refer to criteria A and B of the criteria sets for withdrawal from the specific substances) (b) the same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms 3 the substance is often taken in larger amounts or over a longer period than was intended 4 there is a persistent desire or unsuccessful efforts to cut down or control substance use 5 a great deal of time is spent in activities necessary to obtain the substance (e.g. visiting multiple doctors or driving long distances), use the substance (e.g. chain-smoking), or recover from its effects 6 important social, occupational, or recreational activities are given up or reduced because of substance use 7 the substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance (e.g. current cocaine use despite recognition of cocaineinduced depression, or continued drinking despite recognition that an ulcer was made worse by alcohol consumption)
Criteria for substance abuse A A maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by one (or more) of the following, occurring within a 12-month period: 1 recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (e.g. repeated absences or poor work performance related to substance use; substance-related absences, suspensions, or expulsions from school; neglect of children or household) 2 recurrent substance use in situations in which it is physically hazardous (e.g. driving an automobile or operating a machine when impaired by substance use) 3 recurrent substance-related legal problems (e.g. arrests for substance-related disorderly conduct) 4 continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e.g. arguments with spouse about consequences of intoxication, physical fights) B The symptoms have never met the criteria for substance dependence for this class of substance focusing on the design and instruments chosen for the baseline investigation and the subsequent follow-up. The basic prerequisite for addressing the main objectives of the EDSP, outlined below, is the use of substancespecific diagnostic criteria allowing the determination of the lifetime and current prevalence of symptoms of abuse and dependence according to the explicit diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th revision (DSM-IV) [1] with an appropriate reliable and valid casefinding instrument. These criteria are comparable to the research criteria of the tenth version of the International Classification of Diseases (ICD-10) [2] . These new criteria enable researchers and clinicians to classify dependence and abuse for each specific group of the following classes of substances: alcohol, amphetamines, cannabinoids, cocaine, hallucinogens, inhalants, opioids, phencyclidine, sedatives/hypnotics/anxiolytics and others. Additionally, dependence may also be diagnosed for nicotine and polysubstance use (table 1) .
Objectives of the EDSP
With its focus on the early stages of substance abuse the EDSP has three primary objectives:
(1) Determination of lifetime and cross-sectional prevalence and 1-to 4-year incidence of substance use, abuse and dependence of various substances (nicotine, alcohol, all types of illegal as well as prescription drugs) along with information about mode and time of onset as well as associated sociodemographic risk factors in a representative population sample.
(2) Description of the natural course of substance use patterns over a period of several years with emphasis on the identification of developmental stages of substance disorders and their relationship to various risk and protective factors, associated with changes from one stage to another.
(3) Examination of the association of substance use disorders with other psychopathological variables, including temporary and secondary mental disorders as well as disorders in the respondents' family (family genetic factors).
Secondary objectives -along with supplementary projects -are: (4) Identification of family genetic factors through separate interviews with the respondents' parents to assess the parents' psychopathology, illness histories as well as the respondents' childhood history and early behavioral problems as potentially important vulnerability and risk factors for later substance abuse patterns. In addition, the family atmosphere as well as child-rearing styles are evaluated.
(5) Supplementary experimental investigations (population lab) in high-risk respondents to assess the critical role of neurobiological and cognitive dysfunctions in stress and anxiety regulation as predictors for later substance abuse.
Design and Methods
Overall Design Issues
The overall design chosen to investigate these issues is a prospective longitudinal design based on a random population sample of residents in the Munich area, aged 14-24 years. The lower age limit of 14 years was chosen, because first substance use exposure (nicotine, alcohol) has been reported to occur at a fairly young age (13-15 years), with other substances usually being reported later in adolescence. This lower age limit is also reasonable in terms of the instruments used, because the age of 14 is the youngest age for which some psychometric investigations are available for the EDSP core instruments (see below). As an upper limit for inclusion, the age of 24 years was chosen. The regional restriction to Munich residents allowed and facilitated the conduct of above-mentioned family genetic, as well as supplementary in-depth analysis of high-risk respondents at reasonable costs.
For practical and theoretical reasons we also limited the number of follow-up investigations over the 5-year funding period to three waves. As emphasis was laid on early stages of substance abuse patterns, subjects aged 14-17 years old at baseline were examined three times (baseline, T1 and T2) with approximately 18-month time intervals, whereas subjects aged 18-24 years were assessed only twice (baseline and 36 months later). Thus, overall, a period of almost 4 years will be covered.
The family assessments as well as the laboratory studies were conducted almost exclusively in the time between the baseline (T0) and T1 follow-up interview, in order to use the data as predictors for outcome at the final assessment. Separate face-to-face interviews with the respondents' parents were carried out to evaluate childhood development and childhood disorders together with family genetic variables. Figure 1 gives a graphical representation of the overall design.
Sampling and Response Rates
The sample was drawn in November 1994 from the respective population registry offices (Einwohnermel- deämter, see below) of the city and each of the 29 counties of Munich. The base population were all those born between June 1st 1970 and May 31st 1981, registered as living in these localities as their primary place of residence and having German citizenship. These registers can be regarded as highly accurate because of regular updates as well as strict enforcement by law and the police. Munich (population 2.6 million) is the capital of Bavaria with a high proportion of the population being employed in education and service settings (32%) followed by manufacturing industries (22%) and trade (18%). As in other German metropolitan areas, there is a considerable proportion of foreign guest workers and migrants (21%). Compared with other cities in Germany, only a relatively small proportion of Munich's residents are unemployed (6%) at the time of the baseline assessment.
The random sample was proportionally drawn to mirror the distribution of 14-to 24-year-olds in Munich. Based on our power calculation for substance use we determined that we needed at least 3,000 respondents for the descriptive epidemiological part of the study. Because the study is designed as a longitudinal panel with special interest in the development of substance disorders, we had to make sure that we attained a sufficiently high number of subjects without any substance use at baseline. Therefore, we sampled a disproportionately high number of 14-and 15-year-old subjects. This was necessary as these age groups are those with the least number of members in the population. Fourteen-to 15-year-olds were sampled at twice the probability of persons 16-21 years of age, and 22-to 24-year-olds were sampled at half this probability.
From the total of 4,809 sampled individuals, 4,263 were located and determined to be eligible for the study. Sampled individuals who were not located were disproportionately older and uncontactable either because they had moved outside the metropolitan Munich area in the time interval between their registration and the beginning of the study in 1995 (8.8%) or could not be associated with the listed address during the field work period (2.4%).
From the 4,263 individuals a total of 3,021 interviews were completed resulting in a response rate of 71%. In addition, partial information was obtained on an additional 6.2% but these findings will not be reported here. Refusal to participate (18.2%) was by far the most frequent reason for nonresponse followed by a reported lack of time (3.3%), failure to contact anyone in the identified household (3.1%) and failure to contact the sampled individual in an identified household (3.0%). Demographically, nonresponse increased with age, especially among women whose nonresponse rates were slightly higher than those of men among individuals of 18+ years of age (table 2). The slightly higher proportion of refusals among women was due to increased reports of lack of time, failure to contact anyone in the household and failure to contact the sampled individual. Because previous studies have found non-response and attrition to be significantly higher among persons with psychiatric disorders [3] [4] [5] , future analyses will examine this area in more detail.
To account for the differential sampling probabilities and nonresponse oversampling of persons expected to be 14-15 years of age at interview and undersampling of 21-to 24-year-olds, individuals who were not located as well as nonresponse, the data have been adjusted by age, sex and geographic location to match the distribution of the sampling frame. Table 2 presents the demographic distribution of the sample and respondents and shows the decreasing response rates with age, the adjusted distribution of respondents that results from using weighted data, and a comparison of the weighted respondent distribution to that of metropolitan Munich. Table 3 shows the distribution of some sociodemographic variables in the sample. Approximately one-third is currently attending or has attended gymnasium (secondary education between ages of 10 and 19 that prepares students for entrance to university) and another third university. Lower school educational status is reported by 11% (Grund-or Hauptschule = mandatory basic school) and (Realschule = an intermediate type of advanced school between Gymnasium and Hauptschule allowing qualification for specific university curricula) by 18.4%. Consistent with the mandatory schooling laws, there are only 0.5% that have dropped out of any type of these schools completely without any sort of qualification. Only 22.6% of all study participants are currently in the work force and 4.9% are registered as being unemployed. The majority of respondents are currently living with their parents, only a few are currently married. The vast majority of respondents were classified as middle class, with only 7.8% belonging to the lower social classes.
Diagnostic Assessment
Psychopathological and diagnostic assessments were based on the Computer-Assisted Personal Interview (CAPI) version of the Munich-Composite International Diagnostic Interview (M-CIDI) [6, 7] .
The M-CIDI is a modified version of the World Health Organization (WHO) CIDI, version 1.2 supplemented by questions to cover DSM-IV and ICD-10 criteria [6, 7] . The M-CIDI (table 4) allows for the assessment of symptoms, syndromes and diagnoses of 48 mental disorders (not counting various subtypes of main disorders) along with information about onset, duration, clinical and psychosocial severity (see table 4 ). Diagnostic analysis is based on the M-CIDI diagnostic package DSM-IV diagnostic algorithms [8] . Diagnostic findings reported in this paper are based on the M-CIDI/DSM-IV algorithms without using the DSM-IV hierarchy rules, unless otherwise stated in the text.
The M-CIDI inlcudes numerous features that have been developed and tested in several methodological studies with the CIDI or modifications thereof [9] . These include: (a) the use of symptom lists and memory aids that are assembled in a separate response booklet to improve lifetime recall, ease memory search and shorten length of the inverviews in the somatization and anxiety section; (b) the addition of symptom and criteria lists to help the proband answer onset and recentness questions, for example, in the alcohol section to assess onset and recentness of reported dependence symptoms; (c) the implementation of dimensional ratings various sections for the assessment of impairment associated with core syndromes; (d) the rating of key syndromes specifically for their first, worst and most recent occurrence, with additional questions to allow derivation of pure cross-sectional measures; (e) the incorporation of dimensional symptom scales such as the SCL-90-R [10] , behavioral inhibition and premenstrual syndrome into the interview to enable us to measure changes in key psychopathological dimensions; (f) the implementation of separate current and lifetime ratings for the degree of impairment in var- ious social roles (work, school, leisure time, partner, etc.) for each diagnostic section; (g) the addition of more openended questions describing the person's problems, allowing the clinical editor to judge the appropriateness of the CIDI ratings; (h) the abandonment in some sections of the symptom-specific probe questions of the original CIDI in favor of syndrome-based coding, and (i) the deletion of many of the CIDI's skip rules in several diagnostic sections to allow for the study of subthreshold conditions (i.e. mixed anxiety-depression disorders and brief recurrent syndromes) and to improve the CIDI's ability to measure more subtle changes in diagnostic status because we expect considerably less diagnostic stability in adolescents than in adults. The mean duration for completing the computerized (CAPI) M-CIDI, including questionnaires, was two hours. The decision to use the CAPI-CIDI was made after the pilot test where CAPI interviews were shown to reduce the length of interview administration and to help avoid interviewer coding, skip rule and probe question errors. The CAPI version of the M-CIDI was supplemented by a separate respondents' booklet that included several scales and questionnaires that were of importance for the longitudinal component of our study. In addition, there were cognitive aids to help and assist the respondent in dating symptom onset and recency and in answering complicated symptom questions and identifying course patterns. More detailed information on the substance section of the M-CIDI along with data about its reliability are reported elsewhere in this issue.
Other Instruments and Constructs
The study uses primarily standardized instruments (questionnaires and interviews) with known psychometric properties to measure psychopathology as well as explanatory constructs. The fairly high number of interviewers with various theoretical backgrounds and experience as well as the stability with which these instruments are applied over the study period made high reliability as well as standardization a basic requirement in choosing instruments. Table 5 briefly describes the main instruments and constructs with their average administration time.
Interviewers and Interviewer Training
The length of the study period made it unlikely to use the same interviewers throughout the whole study. Interviewers were carefully selected from two sources with prior expertise in health or clinical interviewing as the first and primary selection criterion. The first source was clinical interviewers from other projects of our unit with experience in conduction CIDI interviews. Most of these staff members were psychologists in postgraduate training for psychotherapy, most of whom were also involved over a period of at least 6 months in the further development of the M-CIDI as well as other study instruments (pilot studies). The second source were full-time professional health research interviewers. The health research interviewers were recruited from Infratest-Gesundheitsforschung, a survey company specializing in health research, commissioned to perform the sampling and field work coordination in the baseline phase of the EDSP. These survey interviewers from Infratest were however only used in the baseline investigation because of the relatively high costs involved. In addition, assessment in the subsequent follow-ups T1 and T2 required some clinical ratings by the interviewers to map the clinical course of disorders.
All interviewers underwent several screening stages and were finally chosen from an initial group of 67 applicants. Ten clinical interviewers and 25 health survey interviewers with varying professional backgrounds did all the assessments in the baseline interview. They had all received 2 full weeks of training, which included the CIDI standard training components. This training period was followed by at least 10 practice interviews that were closely monitored by our staff. Immediately prior to the beginning of the study, 1 day of pre-field training was done to stress the important points and techniques and increase the motivation of the interviewers.
Field Work
To assist interviewers in establishing contacts or with technical issues and to answer any questions from probands, a telephone hotline was installed. After contacting the probands by letter and phone, a time and location for the interview was added. Most interviews took place at the time of first contact which was in the proband's home. At the beginning of the interview the written data protection explanation was given to the probands and a gift was given as an incentive for participation. The standard gift was two telephone cards each worth DM 12 (USD 8).
To enhance participation, several special efforts were made during the study: (a) the addresses of at least 4 contacts were given to another interviewer of the opposite sex and, overall, at least 10 attempts at contact (maximum 15) were made at different times of the day and week including weekends; (b) interviewers who were especially successful at contacting were trained for recontacting difficult-to-contact probands; (c) motivation letters were sent to 100 unreachable probands with a telephone card enclosed and the request to call back, and (d) to motivate the last indecisive probands, up to DM 60 (USD 40) was offered. The 71% response rate with a total of n = 3,021 completed interviews was reached by the end of July 1995. In the beginning of the study the interviewers had to contact the editors after having completed three to five interviews and, throughout the field period, when handing over completed interviews. This gave interviewers the opportunity to receive help regarding technical and content aspects of the interview.
Interviewers were closely monitored throughout the field period by both the Infratest field staff as well as specially trained M-CIDI clinical editors. This procedure ensured that within a week of submission to the clinical editor interviews were checked according to a standard procedure for both formal consistency as well as appropriate recording techniques. During these weekly editing sessions, detailed feedback was given to every interviewer to avoid erros in later interviews. The personal feedback for interviewers was maintained throughout the study to assure a high quality of administration and to motivate the interviewers. The editors also gave instructions for reassessments of missing values or questionnaires. The correct administration of interviews was checked by random follow-up phone calls to probands.
Statistical Analyses
As described above ( fig. 1) , the EDSP study design calls for a baseline assessment (T0) and two follow-up interviews (T1, T2) at approximately 18-month intervals, thereafter the first of which (T1) is administered only to the subpopulation of respondents initially 14-17 years of age. Following this longitudinal panel design, lifetime symptomatology is assessed at baseline with the lifetime version of the M-CIDI allowing for cross-sectional 12-month diagnoses as well as the retrospective assessment of prior syndromes prior to the 12 months. Thus, these baseline data also allow for evaluating onset, course and remission characteristics with the important caveat that these data are retrospective. Nevertheless, in this issue we report such retrospective data about prior lifetime course of disorders in order to develop and tentatively test hypotheses that will be subject to a more rigorous test on the basis of the forthcoming prospective data. Interim symptomatology between the baseline and the two subsequent follow-up investigations is assessed at each followup by using the M-CIDI 12-months version. Because it is technically not feasible to keep a constant time interval between follow-up investigations, because of the considerable number of cases as well as the variations in which they are willing to participate, we assess both 12-month as well as interim symptomatology.
Sample and Weighting
Because the data collected as part of the EDSP study is meant for use in descriptive as well as analytical research, stratified sampling was incorporated into the panel design with 14-to 15-year-olds being sampled at twice the probability of 16-to 21-year-olds and 22-to 24-year-olds being sampled at half this probability. This sampling strategy allows for sufficient precision in not only the estimation of measures for the entire population, i.e. 14-to 24-year- Incidence incidence refers to new outcomes among members of the population at risk; two measures of incidence are the incidence density, a rate, and cumulative incidence: a proportion; other measures of incidence which are often presented as proportions include; first incidence, recurrence, and total incidence Prevalence prevalence refers to all outcomes which exist within a specified time frame; prevalence includes not only incident outcomes such as first incidence and recurrence but also persistent outcomes First incidence, % incident episode in the T0 population without a previous episode
Recurrence, % incident episode in the T0 population with a previous episode but not in an episode at baseline Total incidence, % incident episode in the T0 population with no episode at baseline, regardless of past episode experience; the total of first incident and recurrent outcomes
Persistence or chronicity, % the continuation of a diagnosis episode from one time frame to a subsequent time frame in the absence of interim remission Remission, % a state of subthreshold diagnosis having been preceded by a threshold diagnostic state; the subthreshold state can be described as partially or fully remitted
Odds ratio a single summary measure which estimates the strength and nature of association between an exposure and an outcome is the odds ratio (OR); in the odds ratio, the numerator is the odds of an outcome among those with an exposure (a/c) and the denominator is the odds of an outcome among those without an exposure (b/d); an OR equal to 1.0 indicates no relationship between the exposure and outcome, an OR greater than 1.0 represents a positive relationship, and an OR less than 1.0 represents a negative relationship between the exposure and outcome
Hazard rate the hazard rate is interpreted as the instantaneous potential for the outcome of interest to occur, given it has not occurred at an earlier time point
Cumulative incidence cumulative incidence is analogous to the failure function, the complement of the survival function, and describes the probability of outcome occurrence before time t olds, but also in the estimation of measures used for comparative analyses within the age group of primary interest, i.e. 14-to 15-year-olds. As a result of the stratified sampling design, relative weights inversely proportional to the sampling fraction are used in the estimation of measures which are generalized to the sampling frame. This means that 14-to 15-year-olds receive a weight of ½, reflecting their probability of selection which is twice that of 16-to 21-year-olds, and 22-to 24-year-olds receive a weight of 2, reflecting their probability of selection which is one-half that of 16-to 21-year-olds. In addition, a nonresponse weight is used which adjusts the age, gender and geographic distribution of the respondents to that of the registered sampling frame (see Lee et al. [11] for further explanation).
Measures
The two most common measures used throughout the following papers will be lifetime and 12-month prevalence. Because lifetime prevalence is defined as the cumulative incidence [12, 13] only the incident episode of the diagnosis is counted and by definition the incident episode has met full criteria for dependence. However, in the estimation of 12-month prevalence, respondents experiencing incident episodes in the past 12 months are counted together with respondents experiencing a recurrent episode or a persistent episode in the past 12 months, which need only express one of the dependence symptoms. To clarify this distinction, what has historically been referred to as lifetime prevalence is sometimes referred to in the following papers as lifetime cumulative incidence (table 6) .
To account for the bias introduced by the differing lenghts of follow-up time for each respondent, i.e. they have different ages, survival analysis was used in analyzing the data where appropriate [12, [14] [15] . Hazard and cumulative incidence curves for age at first drink and alcohol diagnoses were calculated using life table methods and the comparison of curves was done using the log-rank test. In the figures which are presented for the alcohol diagnoses, the hazard can be interpreted as the age-specific risk for the outcome and the failure function, the complement of the survival function, as the cumulative incidence, a proportion whose numerator consists of a count of incident outcomes and denominator of a count of the population at risk. These interpretations of the hazard and failure functions are based on the assumptions that the hazard is constant across a given age interval allowing it to be interpreted as a uniform rate within the interval and that low rates are an accurate approximation of the risk.
Conclusion
To conclude, the EDSP can be regarded as both a more descriptive prevalence and incidence study of mental disorders, with emphasis on various substance use syndromes and disorders as well as a causal epidemiological investigation of vulnerabilities, risk and resilience factors. These two objectives require a complex design and a comprehensive assessment of various domains that can best be described as a population laboratory. This means, by selecting subgroups from the representative sample of interest for more in-depth studies, such as case-control or experimental studies in high-risk subjects, we use our sample of 3.021 as a laboratory from which subjects can be selected. This offers the possibility -unlike to studies in patient and convenience samples -to study key hypotheses in the area of substance abuse, such as about the influence of family genetic variables or on the critical role of stress-dysregulation patterns [16] in groups of cases that could be still representative for the respective target population.
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